AzTrials
AzTrials

Chronic PainNCT05700383

The Thrive Study: Improving Multimodal Physical Function in Adults With Heterogenous Chronic Pain

A study testing GetActive-Fitbit and Healthy Living for Pain in people with Chronic Pain, run by Massachusetts General Hospital at 3 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The investigators aim to conduct a randomized controlled trial to test the feasibility of a mind-body walking program compared to a health education program for individuals with chronic musculoskeletal pain. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Chronic Pain
What is being tested?
GetActive-Fitbit and Healthy Living for Pain
Could I receive a placebo?
No, everyone receives an active treatment
How many people
92 participants
Where
3 sitesUnited States
Study dates
1 Apr 2023to 1 Oct 2024
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Male and female outpatients, age 18 years or older
  • Fluent in English
  • Have nonmalignant chronic musculoskeletal pain for more than 3 months
  • Able to perform a 6-minute walk test (6MWT)
  • Owns a smartphone with Bluetooth 4.0 or computer
  • Willingness and ability to participate in one of the 2 programs and to comply with the requirements of the study protocol.
Show all 11Show fewer
  • Free of concurrent psychotropic medication for at least 2 weeks prior to initiation of treatment, OR stable on current medication for a minimum of 6 weeks and willing to maintain a stable dose
  • Low-level of activity (must meet 2/3 criteria; if difficult to assess, recruiter may ask participant to report their recent step data from their smartphone to better understand their activity level)
  • Sitting for more than 8 hours/day per self-report
  • Exercising for fewer than 3 days/week (30+min of exercise constitutes an "exercise day") per self-report
  • Walking for fewer than 7 days/week (30+min of walking constitutes a "walking day") per self-report

Who cannot join

  • Diagnosed with a medical illness expected to worsen in the next 6 months (e.g., malignancy)
  • Serious mental illness or instability for which hospitalization may be likely in the next 6 months
  • Current active suicidal ideation reported on self-report
  • Untreated and/or unstable schizophrenia, bipolar disorder, or other psychotic disorder
  • Current, active substance abuse or dependence, and current alcohol dependence within the past 6 months
  • Practice of yoga, meditation, guided imagery or other mind body techniques that elicit the RR, once per week for >45 min 3 times/week within the last 3 months or less.
Show all 9Show fewer
  • Regular use of Fitbit DMD in the last 3 months
  • Unable to walk/in a wheelchair
  • Mild cognitive decline for participants 65+ only (Short Portable Mental Status Questionnaire; PMSQ 4 or more errors).

Trial locations and contacts

3 sites in 1 country.

United States3 sites
  • Massachusetts General Hospital

    Boston, Massachusetts, 02114

  • Rush Medical Center

    Chicago, Illinois, 60612

  • Duke University

    Durham, North Carolina, 27705

Other trials in United States

About this study

Official title: The Thrive Study: Improving Multimodal Physical Function in Adults With Heterogenous Chronic Pain: Multi-site Feasibility RCT

The investigators aim to conduct a randomized controlled trial to test the feasibility of a mind-body walking program compared to a health education program for individuals with chronic musculoskeletal pain. The investigators will assess the feasibility of recruitment procedures (enrollment, recruitment of racial and ethnic minorities) and intervention delivery (fidelity, adherence, credibility, satisfaction, optimization), following pre-specified benchmarks. Both programs will be delivered in-person.

Read the detailed description

The investigators aim to conduct a randomized controlled trial to test the feasibility of a mind-body walking program (GetActive-Fitbit) compared to a health education program (Healthy Living for Pain) for individuals with chronic musculoskeletal pain. The investigators will assess the feasibility of recruitment procedures (enrollment, recruitment of racial and ethnic minorities) and intervention delivery (fidelity, adherence, credibility, satisfaction, optimization), following pre-specified benchmarks. Both programs will be delivered in-person.

Each program will consist of ten 60-minute sessions in-person. Participants will receive a treatment manual and ActiGraph watch to assess physical function. There are 3 assessment points consisting of self-report surveys and performance-based measures: baseline, post-program, and 6-month follow-up. All participants will receive access to the other program's manual and website after completing the six-month follow-up.

Conditions
Chronic Pain
Being tested
GetActive-Fitbit, Healthy Living for Pain
Keywords
Chronic Pain, Physical Function, Mindfulness
Medical subject headings
Chronic Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • GetActive-FitbitBehavioural

    GetActive-Fitbit is an adaptation of the original GetActive-Fitbit program, a mind-body program for the unique needs of individuals with chronic musculoskeletal pain that incorporates activity skills to help individuals improve all aspects of physical function. The GetActive-Fitbit sessions address mind-body skills (e.g., mindfulness, deep breathing, self-compassion), walking skills (e.g., step goals, quota-based pacing), and skills to change thinking (e.g., identify unhelpful thoughts about pain and activity, challenging thoughts). The format is a 10-week program delivered in-person with weekly group sessions and home practice of skills and walking.

  • Healthy Living for PainBehavioural

    Healthy Living for Pain is an active intervention that will be dose, attention, and time matches to the GetActive-Fitbit program. Healthy Living for Pain is an adaptation of the Health Enhancement Program, developed by Dr. Vranceanu and colleagues from Stony Brook, with adjustments for patients with chronic musculoskeletal pain. The Healthy Living for Pain sessions provide educational information on chronic musculoskeletal pain, the role of sleep and nutrition, physical activity, healthcare management, medication use, and social connection. The format is a 10-week program delivered in-person with weekly group sessions and home practice journaling.

Study groups in NCT05700383
Study groupRoleWhat they receive
GetActive-FitbitExperimentalGetActive-Fitbit is an adaptation of the original GetActive-Fitbit program, a mind-body program for the unique needs of individuals with chronic musculoskeletal pain that incorporates activity skills to help individuals improve all aspects of physical function. The GetActive-Fitbit sessions address mind-body skills (e.g., mindfulness, deep breathing, self-compassion), walking skills (e.g., step goals, quota-based pacing), and skills to change thinking (e.g., identify unhelpful thoughts about pain and activity, challenging thoughts). The format is a 10-week program delivered in-person with weekly group sessions and home practice of skills and walking.
Receives: Behavioral: GetActive-Fitbit
Healthy Living for PainActive comparatorHealthy Living for Pain is an active intervention that will be dose, attention, and time matches to the GetActive-Fitbit program. Healthy Living for Pain is an adaptation of the Health Enhancement Program, developed by Dr. Vranceanu and colleagues from Stony Brook, with adjustments for patients with chronic musculoskeletal pain. The Healthy Living for Pain sessions provide educational information on chronic musculoskeletal pain, the role of sleep and nutrition, physical activity, healthcare management, medication use, and social connection. The format is a 10-week program delivered in-person with weekly group sessions and home practice journaling.
Receives: Behavioral: Healthy Living for Pain

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Recruitment Feasibility (Ability)

    Ability to enroll 80% or more of the sedentary chronic pain patients who meet study criteria.

    Measured: 1 Year

  2. Recruitment Feasibility (Timeliness) - Number of Participants Recruited in 1 Year

    Timeliness of enrollment; we will recruit a sample of 90 patients across the 3 sites over the course of 1 year. Participants will be considered enrolled upon randomization. Assessed by the number of participants enrolled in the study over the course of 1 year. If number enrolled meets or exceeds goal of 90 participants, the benchmark is considered met.

    Measured: 1 Year

  3. Feasibility of Recruitment Racial and Ethnic Minorities

    38% or more of the entire sample will be comprised of racial and ethnic minorities, which is consistent with the current USA demographic distribution.

    Measured: 1 Year

  4. Intervention Feasibility/ Adherence to Sessions

    ≥80 chronic pain patients attend ≥7/10 sessions for each program (70%)

    Measured: Post-Test (10 Weeks)

  5. Credibility and Expectancy Scale - Credibility

    ≥80 chronic pain patients with credibility scores higher than the Credibility and Expectancy Scale credibility subscale's mid-point, indicating intervention credibility. Credibility subscale scores range from 3 to 27. Higher scores indicate higher perceived credibility for the program.

    Measured: Baseline (0 Weeks)

  6. Client Satisfaction Scale

    ≥80 chronic pain patients with satisfaction scores higher than the scale's mid-point, indicating intervention satisfaction.

    Measured: Post-Test (10 Weeks)

  7. Retention

    ≥80 post-treatment, ≥75% 6 months follow up for self-report, performance based and Actigraph data (this includes valid data for all participants).

    Measured: Post-test (10 weeks), Follow-up (24 weeks)

  8. Assessment Feasibility

    We calculated the proportion of assessment procedures that were administered as intended in the the checklists of the study protocol. The number of assessment procedures that were administered in line with the study's protocol checklists was divided by the total number of assessment procedures. The benchmark was set to 90%, i.e., assessment procedures were deemed feasible if ≥90% of assessment procedures were delivered as specified in the protocol.

    Measured: 1 Year

  9. Credibility and Expectancy Questionnaire - Expectancy

    ≥80 chronic pain patients with expectancy scores higher than the subscale's mid-point, indicating intervention expectancy. Expectancy subscale scores range from 3 to 27. Higher scores indicate more belief that treatment will help.

    Measured: Baseline (0 weeks)

Secondary outcomes (11)
  1. Pain, Enjoyment of Life and General Activity (PEG-3) Scale

    Rate of a participant's pain intensity and related interference in enjoyment of life and general activity, using a 0-10 Likert scale. Scores range from 0-30 with higher scores indicating greater pain and interference.

    Measured: Baseline (0 Weeks), Post-Test (10 Weeks), Follow-Up (24 Weeks)

  2. WHO Disability Assessment Schedule 2.0 (WHODAS)

    The WHODAS measures level of functioning in six domains: cognition, mobility, self-care, getting along, life activities, and participation. Each question on the scale is measured 0-4. The score range is 0-100, with higher scores indicating more disability.

    Measured: Baseline (0 Weeks), Post-Test (10 Weeks), Follow-Up (24 Weeks)

  3. 6 Minute Walk Test (6MWT)

    The 6MWT is a performance-based measure that assesses physical function and endurance.

    Measured: Baseline (0 Weeks), Post-Test (10 Weeks), Follow-Up (24 Weeks)

  4. ActiGraph GT9X

    The ActiGraph GT9X is a step count device that objectively measures function (number of steps).

    Measured: Baseline (0 Weeks), Post-Test (10 Weeks), Follow-Up (24 Weeks)

  5. PROMIS Depression v1.08b

    The PROMIS depression v1.08b measures negative mood, views of self and cognitions on a 5-point scale. Raw scores are converted into a t-score with a mean of 50 and standard deviation of 10. Higher scores indicate more depressive symptoms.

    Measured: Baseline (0 Weeks), Post-Test (10 Weeks), Follow-Up (24 Weeks)

  6. PROMIS Anxiety v1.08a

    The PROMIS anxiety v1.08a measures fear, worry, hyperarousal and somatic symptoms. Each item is rated on a 1-5 point Likert Scale and raw scores are converted to t-scores with a mean of 50 and a standard deviation of 10. Higher scores indicating more anxiety symptoms.

    Measured: Baseline (0 Weeks), Post-Test (10 Weeks), Follow-Up (24 Weeks)

  7. Pain Catastrophizing Scale (PCS)

    A 13-item questionnaire assessing one's tendency to focus on pain-related thoughts and feel helpless and hopeless due to pain on a scale of 0 to 4. Higher scores indicate higher pain catastrophizing. Scores range from 0 to 52.

    Measured: Baseline (0 Weeks), Post-Test (10 Weeks), Follow-Up (24 Weeks)

  8. Tampa Kinesiophobia Scale (TSK)

    A 17-item questionnaire that assesses fear avoidance and fear of activity. Higher scores indicate higher kinesiophobia. Scores range from 17 to 68.

    Measured: Baseline (0 Weeks), Post-Test (10 Weeks), Follow-Up (24 Weeks)

  9. Measure of Current Status (MOCS)

    The MOCS questionnaire assesses ability to engage in a series of healthy coping skills (e.g., relaxation, social support, adaptive thinking). Higher scores indicate a stronger ability to recognize stress and cope, with scores ranging from 10 to 50.

    Measured: Baseline (0 Weeks), Post-Test (10 Weeks), Follow-Up (24 Weeks)

  10. Cognitive and Affective Mindfulness Scale (CAMS)

    Rate of a participant's broad conceptualization of mindfulness, items range from 1-4. Higher values reflect higher levels of mindfulness. Scores range from 12 to 48.

    Measured: Baseline (0 Weeks), Post-Test (10 Weeks), Follow-Up (24 Weeks)

  11. Modified Global Impression of Change (MGIC)

    3-items assessing the extent to which patients perceive the intervention improved functioning and symptoms. Each item is rated on a 1-7 point scale with higher scores indicated greater perceived improvement.

    Measured: Baseline (0 Weeks), Post-Test (10 Weeks), Follow-Up (24 Weeks)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jan 2023
  2. Study start1 Apr 2023
  3. Primary completion1 Oct 2024
  4. Study completion1 Oct 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
92 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05700383
Sponsor's protocol ID
2023P000321
Other IDs
1R01AT012069-01
Status last verified
Jan 2026
First submitted
17 Jan 2023
Last updated
28 Jan 2026
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Greenberg J, Hooker JE, McDermott KA, La Camera DE, Brewer JR, Szapary CL, Somers TJ, Keefe F, Kelleher SA, Fisher HM, Burns J, Jeddi R, Kulich R, Polykoff GI, Parker RA, Vranceanu AM; THRIVE Study Team; Diachina A, Hogan S, Chou N, Yates L. Feasibility of a Mind-Body Program for Chronic Pain: A Randomized Clinical Trial. JAMA Netw Open. 2025 Jun 2;8(6):e2515685. doi: 10.1001/jamanetworkopen.2025.15685.

    PubMed 40522662
  • Hooker JE, Brewer JR, McDermott KA, Kanaya M, Somers TJ, Keefe F, Kelleher S, Fisher HM, Burns J, Jeddi RW, Kulich R, Polykoff G, Parker RA; THRIVE Study Team; Greenberg J, Vranceanu AM. Improving multimodal physical function in adults with heterogeneous chronic pain; Protocol for a multisite feasibility RCT. Contemp Clin Trials. 2024 Mar;138:107462. doi: 10.1016/j.cct.2024.107462. Epub 2024 Jan 28.

    PubMed 38286223

Questions about this trial

What is this clinical trial studying?

A study testing GetActive-Fitbit and Healthy Living for Pain in people with Chronic Pain, run by Massachusetts General Hospital at 3 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 16 Jul 2025). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Recruitment Feasibility (Ability) (time frame: 1 Year). The study lists 9 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05700383, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jan 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in